Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| SITAVIA | (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd | Film-coated tablet | Jan 1, 2024 | Generic |
| Malaquon | Hetero Labs Limited Unit – V | Tablet | Jan 1, 2024 | Generic |
| Tacroz | Glenmark Pharmaceuticals Limited - Baddi | Ointment | Jan 1, 2024 | Generic |
| PROVINDA PLUS | SPIMACO | Tablet | Jan 1, 2024 | Generic |
| PROVINDA PLUS | SPIMACO | Tablet | Jan 1, 2024 | Generic |
| Levogand | Acme Generics LLP | Tablet | Jan 1, 2024 | Generic |
| Docrosa | Macleods Pharmaceuticals Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| Ultavan | Inforlife S A | Intravenous infusion | Jan 1, 2024 | Generic |
| Vizoden | UNITED PHARMACEUTICAL COMPANY | Film-coated tablet | Jan 1, 2024 | Generic |
| Docrosa | Macleods Pharmaceuticals Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| NERLYNX | Pierre Fabre Medicament Production | Film-coated tablet | Jan 1, 2024 | NCE |
| Avogesic | (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd | Cream | Jan 1, 2024 | Generic |
| Vizoden | UNITED PHARMACEUTICAL COMPANY | Film-coated tablet | Jan 1, 2024 | Generic |
| Essential D-3 | ARNET PHARMACEUTICAL CORP | Capsule | Jan 1, 2024 | Generic |
| Essential D-3 | ARNET PHARMACEUTICAL CORP | Capsule | Jan 1, 2024 | Generic |
| Daglozin | Sudair Pharma Company | Film-coated tablet | Jan 1, 2024 | Generic |
| Influvac Tetra | ABBOTT BIOLOGICALS | Solution for injection in pre-filled syringe | Jan 1, 2024 | Biological |
| Vizoden | UNITED PHARMACEUTICAL COMPANY | Film-coated tablet | Jan 1, 2024 | Generic |
| Epiduo Forte | LABORATOIRES GALDERMA | Gel | Jan 1, 2024 | NCE |
| Tepkinly | VETTER PHARMA | Solution for injection | Jan 1, 2024 | Biological |
